Pacific Biosciences
PACB
PACB
226 hedge funds and large institutions have $395M invested in Pacific Biosciences in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 77 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less call options, than puts
Call options by funds: $3.31M | Put options by funds: $3.63M
3.88% less ownership
Funds ownership: 88.97% → 85.1% (-3.9%)
12% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 77
Holders
226
Holding in Top 10
4
Calls
$3.31M
Puts
$3.63M
Top Buyers
| 1 | +$9.85M | |
| 2 | +$6.07M | |
| 3 | +$1.64M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.55M |
| 5 |
Morgan Stanley
New York
|
+$1.38M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$7.42M | |
| 3 | -$4.4M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.25M |
| 5 |
VS
VK Services
Menlo Park,
California
|
-$2.24M |